Format

Send to

Choose Destination
Leuk Lymphoma. 2019 Jan;60(1):246-249. doi: 10.1080/10428194.2018.1468893. Epub 2018 Jul 2.

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.

Author information

1
a Department of Internal Medicine, Section of Hematology, Yale University School of Medicine , New Haven , CT, USA.
2
b Department of Biostatistics, Yale School of Public Health , New Haven , CT, USA.
3
c Department of Medicine , University of Valencia, Hospital Universitario y Politécnico La Fe , Valencia, CIBERONC, Instituto III , Madrid , Spain.
4
d Department of Hematology/Oncology, Saint-Louis Hospital, University of Paris 7 , France.
5
e Division of Hematology and Oncology, Weill Cornell Medicine and The New York Presbyterian Hospital , New York , NY , USA.
6
f Leukemia Program Cleveland Clinic , Cleveland , OH , USA.
7
g Massachusetts General Hospital Cancer Center Harvard Medical School , Boston , MA , USA.
8
h Department of Malignant Hematology , Moffitt Cancer Center and Research Institute , Tampa , FL , USA.
9
i Division of Hematology/Oncology, University of Nebraska Medical Center , Omaha , NE , USA.
10
j Mayo Clinic , Rochester , MN , USA.
11
k Cote d'Azur University, Nice Sophia Antipolis University, CHU of Nice , Nice , France.
12
l Division of Hematology , University of Florence , Florence , Italy.
13
m Department of Pharmacy , Yale New Haven Hospital , New Haven , CT , USA.
14
n Department of Hematology , Institut Paoli Calmettes , Marseille , France.
15
o Department of Hematology , Oncology and Clinical Immunology , Heinrich-Heine-University Duesseldorf , Duesseldorf , Germany.
16
p Hospital San Pedro Alcántara , Cáceres , Spain.
17
q Division of Hematology/Oncology, University Hospital Reina Sofia , Cordoba , Spain.

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center